# Delaware Institute for Reproductive Medicine, P.A – FDA Inspection, Mar 31, 2011

Source: https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/eb535461-86b0-4970-b7bf-3c8a75ce3590
Source feed: FDA_Inspections

> FDA inspection 717132 of Delaware Institute for Reproductive Medicine, P.A, March 31, 2011. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 717132
- Company Name: Delaware Institute for Reproductive Medicine, P.A
- Inspection Date: 2011-03-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1293390 - 2025-09-16
- FDA Inspection 1187482 - 2022-10-26
- [FDA Inspection 1094217 - 2019-06-20](https://www.keypedia.com/records/fda_inspections/delaware-institute-for-reproductive-medicine-pa/637058bc-c8e1-4b70-9344-456c2eccbe8a)
- FDA Inspection 1018967 - 2017-06-08
- FDA Inspection 925928 - 2015-05-13

Company: https://www.keypedia.com/companies/delaware-institute-for-reproductive-medicine-pa/15cecf6a-a321-4390-9048-921999542784

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d